10-QPeriod: Q2 FY2024

Bunge Global SA Quarterly Report for Q2 Ended Jun 30, 2024

Filed August 1, 2024For Securities:BG

Summary

Bunge Global SA reported a significant decrease in net income for the second quarter and first half of 2024 compared to the prior year, primarily driven by lower segment earnings before interest and taxes (EBIT) across its core and non-core businesses. Net income attributable to Bunge shareholders was $70 million for the quarter and $314 million for the six months, down from $622 million and $1,254 million, respectively, in the same periods of 2023. This decline is largely attributed to reduced gross margins and lower commodity prices impacting sales across key segments like Agribusiness and Refined & Specialty Oils. Despite the lower profitability, Bunge is actively pursuing strategic transactions. The company is on track to close its significant acquisition of Viterra Limited, which is expected to transform its global agribusiness operations. Concurrently, Bunge is proceeding with the divestiture of its 50% stake in BP Bunge Bioenergia and a 40% stake in its Spanish subsidiary, Bunge Iberica SA. The company maintained solid liquidity with substantial unused committed borrowing capacity, though cash and cash equivalents decreased from year-end 2023, largely due to operating cash usage and share repurchases.

Financial Highlights

54 data points
Beta

Revenue

$13.24B

5.0% Gross Margin

Net Income

$70.00M

0.5% Net Margin

EPS (Diluted)

$0.48

Total Assets

$24.43B

Cash & Equivalents

$1.16B

Free Cash Flow

-$1.77B

Financial Statements
Beta
Revenue$13.24B
Cost of Revenue$12.58B
Gross Profit$664.00M
SG&A Expenses$449.00M
Interest Expense$123.00M
Net Income$70.00M
EPS (Basic)$0.49
EPS (Diluted)$0.48
Shares Outstanding (Basic)141.62M
Shares Outstanding (Diluted)143.19M

Key Highlights

  • 1Net income attributable to Bunge shareholders decreased significantly to $70 million for Q2 2024 and $314 million for the first six months of 2024, down from $622 million and $1,254 million in the respective prior-year periods.
  • 2Total Segment EBIT declined substantially, falling to $185 million in Q2 2024 and $618 million year-to-date, from $912 million and $1,798 million in the comparable periods of 2023, driven by lower gross margins.
  • 3The Agribusiness segment experienced an 82% year-over-year decrease in EBIT for Q2 2024, reflecting challenges in both its processing and merchandising operations, particularly lower gross profit and margins.
  • 4Bunge is advancing its acquisition of Viterra Limited, having secured $8.0 billion in acquisition financing, and anticipates closing the transaction in the coming months.
  • 5The company is divesting its 50% stake in BP Bunge Bioenergia for an estimated $800 million and has entered into an agreement to sell a 40% stake in Bunge Iberica SA for $300 million plus contingent payments.
  • 6Inventories increased by $952 million from year-end 2023 to $8,057 million at June 30, 2024, primarily due to the timing of the South American harvest and increased volumes, partially offset by lower commodity prices.
  • 7The company repurchased $400 million of its shares during the first six months of 2024, as part of its ongoing share repurchase program, with $1.0 billion remaining capacity.

Frequently Asked Questions

The substantial decrease in net income and EBIT is primarily due to lower gross margins and reduced profitability across Bunge's core segments, particularly Agribusiness and Refined & Specialty Oils. This was influenced by factors such as lower average sales prices, stabilization of commodity prices after periods of volatility, and unfavorable mark-to-market results in certain operations.

Bunge has entered into a definitive business combination agreement to acquire Viterra Limited and has secured $8.0 billion in acquisition financing. The transaction is subject to regulatory approvals and other customary closing conditions, with an expected close in the coming months. Upon completion, Bunge expects the acquisition to create a more innovative global agribusiness company, enhancing its market position and ability to serve customers.

Bunge's cash flow from operations has been negative for the first six months of 2024, largely due to lower net income and increased working capital needs, particularly related to inventory. However, the company maintains substantial liquidity with $5,665 million in unused committed borrowing capacity across its revolving credit facilities. Cash and cash equivalents decreased from the end of 2023, reflecting these operational uses and share repurchases.

Bunge is actively divesting non-core assets. This includes the planned sale of its 50% ownership in BP Bunge Bioenergia for approximately $800 million, expected to close in Q4 2024, and the sale of a 40% stake in its Spanish subsidiary, Bunge Iberica SA, for $300 million plus contingent payments, expected to close by late 2024.